Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. More Details
High growth potential and fair value.
Share Price & News
How has Aleafia Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AH is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: AH's weekly volatility (10%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: AH underperformed the Canadian Healthcare industry which returned 33.6% over the past year.
Return vs Market: AH underperformed the Canadian Market which returned 39.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Aleafia Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StAleafia Health's (TSE:AH) Shareholders Are Down 11% On Their Shares
2 months ago | Simply Wall StAnalysts Expect Aleafia Health Inc. (TSE:AH) To Breakeven Soon
3 months ago | Simply Wall StIntroducing Aleafia Health (TSE:AH), A Stock That Climbed 29% In The Last Year
Is Aleafia Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AH (CA$0.41) is trading below our estimate of fair value (CA$9.1)
Significantly Below Fair Value: AH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AH is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.
PE vs Market: AH is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AH is good value based on its PB Ratio (0.8x) compared to the CA Healthcare industry average (4.2x).
How is Aleafia Health forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: AH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AH's is expected to become profitable in the next 3 years.
Revenue vs Market: AH's revenue (31.9% per year) is forecast to grow faster than the Canadian market (6.3% per year).
High Growth Revenue: AH's revenue (31.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AH's Return on Equity is forecast to be high in 3 years time
How has Aleafia Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AH is currently unprofitable.
Growing Profit Margin: AH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AH is unprofitable, and losses have increased over the past 5 years at a rate of 96.5% per year.
Accelerating Growth: Unable to compare AH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.1%).
Return on Equity
High ROE: AH has a negative Return on Equity (-152.04%), as it is currently unprofitable.
How is Aleafia Health's financial position?
Financial Position Analysis
Short Term Liabilities: AH's short term assets (CA$72.1M) exceed its short term liabilities (CA$19.6M).
Long Term Liabilities: AH's short term assets (CA$72.1M) exceed its long term liabilities (CA$38.4M).
Debt to Equity History and Analysis
Debt Level: AH's debt to equity ratio (20%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if AH's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AH has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 32.6% each year
What is Aleafia Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AH's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Geoffrey Benic, also known as Geoff, has been Chief Executive Officer of Aleafia Health Inc since June 28, 2018. Previously, Mr. Benic served as the Regional Director of United Parcel Service Canada Lt...
CEO Compensation Analysis
Compensation vs Market: Geoff's total compensation ($USD862.72K) is above average for companies of similar size in the Canadian market ($USD157.14K).
Compensation vs Earnings: Geoff's compensation has been consistent with company performance over the past year.
Experienced Management: AH's management team is considered experienced (2.5 years average tenure).
Experienced Board: AH's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.9%.
Aleafia Health Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Aleafia Health Inc.
- Ticker: AH
- Exchange: TSX
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: CA$133.849m
- Shares outstanding: 330.49m
- Website: https://www.aleafiahealth.com
Number of Employees
- Aleafia Health Inc.
- 85 Basaltic Road
- L4K 1G4
Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/15 23:14|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.